Frankfurt/Main – Unigestion Private Equity and Apheon are joining forces to drive the further growth of Ortivity Group, one of Germany's leading healthcare platforms for outpatient orthopaedic care. Unigestion Private Equity is acquiring a significant minority stake in Ortivity. Selected new Apheon investors are also acquiring stakes. Apheon will remain the lead investor. The growth capital totalling around 200 million euros was raised as part of a targeted search for partners. The transaction is subject to the usual closing conditions.
A CMS team led by Dr Oliver Wolfgramm and Dr Dirk Baukholt provided legal advice to Philipp Scheier and his private equity team at Unigestion on this complex transaction. The advice particularly included structuring the investment, the legal due diligence focussing on corporate, medical law, compliance and data protection as well as negotiating the complex transaction documentation. The transaction is CMS's first mandate for Unigestion Private Equity and is an important milestone on the way to the further development of German orthopaedics into a modern, outpatient model.
Ortivity has developed into one of the most important outpatient healthcare platforms in Germany in recent years. The company operates over 100 sites across three regional clusters in Germany, offering a full spectrum of orthopaedic services, including diagnostics, anaesthesia, surgery, prevention and aftercare.
Apheon is a pan-European, mid-market private equity firm that manages more than three billion euros in assets from selected global institutional investors and family offices.
Unigestion is a global asset manager specialising in private equity with assets under management of around twelve billion euros. Unigestion's private equity team invests in high-growth and resilient companies in the areas of supply chain efficiency, infrastructure resilience, future of work, healthcare performance and consumer development. Unigestion Private Equity is convinced that better and more consistent investment decisions can be made by using "mind and machine" and has been using its proprietary AI technology PEpper for private equity investments since 2020.
Press contact
presse@cms-hs.com
